What Researchers Did
Researchers reported a rare case of internal carotid artery pseudoaneurysm caused by rhinocerebral mucormycosis and reviewed 40 similar cases from 1980 onwards.
What They Found
They described a 38-year-old Caucasian man with a 3-day history of headache, diplopia, and numbness, who was diagnosed with rhinocerebral mucormycosis and an associated internal carotid artery pseudoaneurysm. The patient received immediate treatment with amphotericin B, atorvastatin, and daily hyperbaric oxygen, followed by endovascular treatment of the pseudoaneurysm and radical surgical debridement of infected tissues.
What This Means for Canadian Patients
Canadian patients diagnosed with late-stage rhinocerebral mucormycosis, especially with internal carotid artery involvement, may benefit from an aggressive multimodal treatment approach. This could include extensive surgical removal of infected tissue, antifungal medication like amphotericin B, atorvastatin, hyperbaric oxygen therapy, and endovascular intervention for associated pseudoaneurysms.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
The authors noted that further research and longer follow-up periods are required to better understand the long-term implications of endovascular coiling and hyperbaric oxygen therapy for rhinocerebral mucormycosis.